{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T08:58:56Z","timestamp":1775811536444,"version":"3.50.1"},"reference-count":97,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ITT"],"DOI":"10.2147\/itt.s370435","type":"journal-article","created":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T12:20:07Z","timestamp":1664367607000},"page":"55-66","source":"Crossref","is-referenced-by-count":10,"title":["A Review of Immunotherapeutic Approaches for Substance Use Disorders: Current Status and Future Prospects"],"prefix":"10.2147","volume":"Volume 11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2119-3991","authenticated-orcid":true,"given":"Muhammet","family":"Celik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Fuehrlein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1177\/003693309704200407","volume":"42","author":"Willis","year":"1997","journal-title":"Scott Med J"},{"key":"ref2","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). 5th ed. American Psychiatric Publishing; 2010."},{"key":"ref3","unstructured":"Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2020 National Survey on Drug Use and Health (HHS Publication No. PEP21-07-01-003, NSDUH Series H-56). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2021. Accessed from: https:\/\/www.samhsa.gov\/data\/. Accessed September 23, 2022."},{"key":"ref4","unstructured":"World Drug Report. United Nations publication, Sales No; 2021."},{"key":"ref5","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/252708a0","volume":"252","author":"Bonese","year":"1974","journal-title":"Nature"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1080\/14760584.2017.1378577","volume":"16","author":"Heekin","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1124\/pr.117.013904","volume":"69","author":"Bremer","year":"2017","journal-title":"Pharmacol Rev"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1126\/science.1135299","volume":"314","author":"Gavin","year":"2006","journal-title":"Science"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1126\/science.1138963","volume":"316","author":"Mata-Haro","year":"2007","journal-title":"Science"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1021\/mp500520r","volume":"12","author":"Lockner","year":"2015","journal-title":"Mol Pharm"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1007\/s00216-015-9223-z","volume":"408","author":"Torres","year":"2016","journal-title":"Anal Bioanal Chem"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/(SICI)1098-2787(1999)18:2<119::AID-MAS2>3.0.CO;2-Z","volume":"18","author":"Pichini","year":"1999","journal-title":"Mass Spectrom Rev"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"10481","DOI":"10.3390\/s150510481","volume":"15","author":"Nguyen","year":"2015","journal-title":"Sensors"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"16361","DOI":"10.1074\/jbc.M116.736660","volume":"291","author":"Yang","year":"2016","journal-title":"J Biol Chem"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"26812","DOI":"10.1021\/acsomega.2c03237","volume":"7","author":"Abucayon","year":"2022","journal-title":"ACS Omega"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1053\/j.semperi.2019.01.001","volume":"43","author":"Lyden","year":"2019","journal-title":"Semin Perinatol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12916-018-1058-y","volume":"16","author":"Chang","year":"2018","journal-title":"BMC Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"290","DOI":"10.15585\/mmwr.mm6911a4","volume":"69","author":"Wilson","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.biopsych.2019.06.020","volume":"87","author":"Bell","year":"2020","journal-title":"Biol Psychiatry"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1021\/jm3013745","volume":"56","author":"Pravetoni","year":"2013","journal-title":"J Med Chem"},{"key":"ref21","unstructured":"New york state psychiatric institute(2020, July-) clinical trials of multivalent opioid vaccine components. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04458545. Accessed July 15, 2022."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.neuropharm.2018.06.026","volume":"138","author":"Nguyen","year":"2018","journal-title":"Neuropharmacology"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jim.2014.01.010","volume":"405","author":"Taylor","year":"2014","journal-title":"J Immunol Methods"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S0006-2952(01)00689-X","volume":"62","author":"Selley","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"9036","DOI":"10.1073\/pnas.1219159110","volume":"110","author":"Schlosburg","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1124\/jpet.112.201194","volume":"344","author":"Raleigh","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41541-017-0013-9","volume":"2","author":"Torres","year":"2017","journal-title":"NPJ Vaccines"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.pnpbp.2013.05.012","volume":"45","author":"Kosten","year":"2013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.drugpo.2015.04.003","volume":"26","author":"Mounteney","year":"2015","journal-title":"Int J Drug Policy"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.forsciint.2018.05.042","volume":"289","author":"Kuczy\u0144ska","year":"2018","journal-title":"Forensic Sci Int"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41541-021-00329-0","volume":"6","author":"Stone","year":"2021","journal-title":"NPJ Vaccines"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1002\/anie.201511654","volume":"55","author":"Bremer","year":"2016","journal-title":"Angew Chem Int Ed Engl"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/s41386-019-0385-9","volume":"44","author":"Townsend","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"107730","DOI":"10.1016\/j.neuropharm.2019.107730","volume":"158","author":"Tenney","year":"2019","journal-title":"Neuropharmacology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1038\/s41386-019-0418-4","volume":"44","author":"Tunstall","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"397","DOI":"10.15585\/mmwr.mm7111a1","volume":"71","author":"Cornelius","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref37","unstructured":"National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. The Health Consequences of Smoking\u201450 Years of Progress: A Report of the Surgeon General. Atlanta (GA): Centers for Disease Control and Prevention (US); 2014."},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"GBD 2019 Tobacco Collaborators. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990\u20132019: a systematic analysis from the Global Burden of Disease Study 2019. Lancet. 2021;397(10292):2337\u20132360.","DOI":"10.1016\/S0140-6736(21)01169-7"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4161\/hv.5.4.7310","volume":"5","author":"Cerny","year":"2009","journal-title":"Hum Vaccin"},{"key":"ref40","first-page":"CD009329","volume":"2013","author":"Cahill","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"ref41","unstructured":"Nabi Biopharmaceuticals. Pharmacoeconomic Assessment in Nabi-4514 and Nabi-4515 Phase 3 Studies. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01178346. Accessed July 14, 2022."},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/add.12573","volume":"109","author":"Hoogsteder","year":"2014","journal-title":"Addiction"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1176\/appi.ajp.2012.12060793","volume":"170","author":"Esterlis","year":"2013","journal-title":"Am J Psychiatry"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1517\/13543784.17.5.691","volume":"17","author":"Cerny","year":"2008","journal-title":"Expert Opin Investig Drugs"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4161\/hv.22060","volume":"9","author":"Goniewicz","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"ref46","unstructured":"Study of TA-NIC to assess the efficacy and safety of the vaccine as an aid to smoking cessation. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/record\/NCT00633321. Accessed July 15, 2022."},{"key":"ref47","doi-asserted-by":"crossref","first-page":"e2547","DOI":"10.1371\/journal.pone.0002547","volume":"3","author":"Cornuz","year":"2008","journal-title":"PLoS One"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1002\/eji.200526285","volume":"35","author":"Maurer","year":"2005","journal-title":"Eur J Immunol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1038\/npp.2015.64","volume":"40","author":"Desai","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"ref50","unstructured":"Selecta Biosciences, Inc. Safety and Pharmacodynamics of SEL-068 vaccine in smokers and non-smokers. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01478893. Accessed July 14, 2022."},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1093\/ntr\/ntt003","volume":"15","author":"Tonstad","year":"2013","journal-title":"Nicotine Tob Res"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.intimp.2015.09.012","volume":"29","author":"McCluskie","year":"2015","journal-title":"Int Immunopharmacol"},{"key":"ref53","unstructured":"Pfizer. A study to assess the safety and tolerability of different doses of PF-05402536 and PF-06413367 in healthy adult smokers. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01672645. Accessed July 14, 2022."},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/j.intimp.2011.07.009","volume":"11","author":"Cornish","year":"2011","journal-title":"Int Immunopharmacol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fncir.2013.00152","volume":"7","author":"Baik","year":"2013","journal-title":"Front Neural Circuits"},{"key":"ref56","unstructured":"NIDA. What is cocaine? National Institute on Drug Abuse website. Available from: https:\/\/nida.nih.gov\/publications\/research-reports\/cocaine\/what-cocaine. 2022 Accessed July 17, 2022."},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1001\/archgenpsychiatry.2009.128","volume":"66","author":"Martell","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0264-410X(92)90030-N","volume":"10","author":"Jertborn","year":"1992","journal-title":"Vaccine"},{"key":"ref59","first-page":"42","volume":"50","author":"Holmgren","year":"1994","journal-title":"Am J Trop Med Hyg"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.drugalcdep.2014.04.003","volume":"140","author":"Kosten","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/npp.2011.200","volume":"37","author":"Wee","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1038\/npp.2013.114","volume":"38","author":"Maoz","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1089\/humc.2013.231","volume":"25","author":"Hicks","year":"2014","journal-title":"Hum Gene Ther Clin Dev"},{"key":"ref64","unstructured":"Weill Medical College of Cornell University. Safety study of a disrupted adenovirus (Ad) serotype cocaine vaccine for cocaine-dependent individuals. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02455479. Accessed July 15, 2022."},{"key":"ref65","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/10550887.2014.969603","volume":"33","author":"Nasser","year":"2014","journal-title":"J Addict Dis"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.drugalcdep.2016.05.019","volume":"166","author":"Gilgun-Sherki","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4155\/fmc.11.194","volume":"4","author":"Narasimhan","year":"2012","journal-title":"Future Med Chem"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cbi.2008.04.024","volume":"175","author":"Gao","year":"2008","journal-title":"Chem Biol Interact"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1038\/sj.npp.1301666","volume":"33","author":"Brimijoin","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"e407","DOI":"10.1038\/tp.2014.48","volume":"4","author":"Howell","year":"2014","journal-title":"Transl Psychiatry"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neulet.2013.02.037","volume":"541","author":"Kosten","year":"2013","journal-title":"Neurosci Lett"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1021\/mp200588v","volume":"9","author":"Treweek","year":"2012","journal-title":"Mol Pharm"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1089\/hum.2011.178","volume":"23","author":"Rosenberg","year":"2012","journal-title":"Hum Gene Ther"},{"key":"ref74","unstructured":"2020 National Survey on Drug Use and Health (NSDUH); 2020. Available from: https:\/\/www.samhsa.gov\/data\/release\/2020-national-survey-drug-use-and-health-nsduh-releases. Accessed July 14, 2022."},{"key":"ref75","doi-asserted-by":"crossref","first-page":"317","DOI":"10.15585\/mmwr.mm6912a1","volume":"69","author":"Jones","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1365-2125.2010.03639.x","volume":"69","author":"Karila","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1039\/D0CB00165A","volume":"2","author":"Lee","year":"2020","journal-title":"RSC Chem Biol"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jamapsychiatry.2020.0246","volume":"77","author":"Paulus","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.1021\/ja108807j","volume":"133","author":"Moreno","year":"2011","journal-title":"J Am Chem Soc"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/ajad.12867","volume":"28","author":"Arora","year":"2019","journal-title":"Am J Addict"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1124\/jpet.106.117150","volume":"322","author":"Peterson","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.drugalcdep.2015.06.014","volume":"153","author":"Miller","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.biopsych.2012.09.010","volume":"73","author":"Miller","year":"2013","journal-title":"Biol Psychiatry"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/ajad.12307","volume":"24","author":"Haile","year":"2015","journal-title":"Am J Addict"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"e0118787","DOI":"10.1371\/journal.pone.0118787","volume":"10","author":"Harris","year":"2015","journal-title":"PLoS One"},{"key":"ref86","unstructured":"InterveXion Therapeutics, LLC. Safety study of Ch-mAb7F9 for methamphetamine abuse. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01603147. Accessed July 15, 2022."},{"key":"ref87","unstructured":"InterveXion Therapeutics, LLC. Study of antibody for methamphetamine outpatient therapy (STAMPOUT). Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03336866. Accessed July 15, 2022."},{"key":"ref88","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1369-1600.2012.00474.x","volume":"19","author":"Watterson","year":"2014","journal-title":"Addict Biol"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1476-5381.2012.02145.x","volume":"168","author":"Simmler","year":"2013","journal-title":"Br J Pharmacol"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2016.12.005","volume":"116","author":"Nguyen","year":"2017","journal-title":"Neuropharmacology"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1007\/s00213-020-05558-0","volume":"237","author":"McClenahan","year":"2020","journal-title":"Psychopharmacology"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"E625","DOI":"10.1208\/aapsj070364","volume":"7","author":"Pertwee","year":"2005","journal-title":"AAPS J"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/15563650.2015.1110590","volume":"54","author":"Tait","year":"2016","journal-title":"Clin Toxicol"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1021\/jacsau.0c00057","volume":"1","author":"Lin","year":"2020","journal-title":"JACS Au"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1124\/jpet.301.2.690","volume":"301","author":"Winger","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.mehy.2015.11.011","volume":"87","author":"Huang","year":"2016","journal-title":"Med Hypotheses"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1021\/acschemneuro.1c00498","volume":"12","author":"Zheng","year":"2021","journal-title":"ACS Chem Neurosci"}],"container-title":["ImmunoTargets and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=84330","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=84330","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T12:21:31Z","timestamp":1664367691000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/a-review-of-immunotherapeutic-approaches-for-substance-use-disorders-c-peer-reviewed-fulltext-article-ITT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":97,"URL":"https:\/\/doi.org\/10.2147\/itt.s370435","relation":{},"ISSN":["2253-1556"],"issn-type":[{"value":"2253-1556","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9]]}}}